ESC Premium Access

Residual platelet reactivity after pre-treatment with ticagrelor prior to primary percutaneous coronary intervention is associated with suboptimal myocardial reperfusion

Presentation

About the speaker

Professor Farzin Beygui

University Hospital of Caen, Caen (France)
4 presentations
0 follower

5 more presentations in this session

Predictive value of platelet reactivity, neutrophil to lymphocyte ratio, and hs-CRP at presentation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention

Speaker: Doctor K. Adatia (Cambridge, GB)

Thumbnail

Is there evidence of a rebound increase in platelet aggregation following withdrawal of Aspirin or Ticagrelor in patients who have previously undergone PCI and coronary stenting?

Speaker: Doctor B. Hennigan (Cork, IE)

Thumbnail

Effect of exercise stress test on platelet function in patients with recent acute myocardial infarction

Speaker: Doctor T. Dalcoquio (Sao Paulo, BR)

Thumbnail

Comparative efficacy of intracoronary agents for acute treatment of coronary no-reflow: a network meta-analysis

Speaker: Associate Professor G. Klappacher (Vienna, AT)

Thumbnail

Late mortality after pharmaco-invasive PCI for STEMI

Speaker: Professor J. French (Liverpool, AU)

Thumbnail

Access the full session

Pharmaco intervention and mechanisms in acute coronary syndromes

Speakers: Professor F. Beygui, Doctor K. Adatia, Doctor B. Hennigan, Doctor T. Dalcoquio, Associate Professor G. Klappacher...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk